NCT00562588View on ClinicalTrials.gov

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

PHASE4CompletedINTERVENTIONAL
Enrollment

551

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 28, 2009

Conditions
Cerebrovascular Accident
Interventions
DRUG

Aggrenox bid (ASA 25mg/Dipyridamole ER 200mg)

DRUG

ASA 100 mg qd

Trial Locations (1)

Unknown

9.182.1 Boehringer Ingelheim Investigational Site, Bad Homburg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00562588 - EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA | Biotech Hunter | Biotech Hunter